10-Q: Xenous Holdings Reports Continued Losses in Q3 2025, Cites Going Concern Uncertainty
Quarterly Report
Xenous Holdings, Inc. reports ongoing net losses and a working capital deficit in its Q3 2025 10-Q filing, raising concerns about its ability to continue as a going concern.
Summary
- Xenous Holdings, Inc. filed its Form 10-Q for the quarterly period ended December 31, 2024.
- The company has no business operations and has not generated any revenue since its inception.
- For the nine months ended December 31, 2024, the company reported a net loss of $46,049, compared to a net loss of $45,462 for the same period in 2023.
- The company's accumulated deficit as of December 31, 2024, was $1,196,015.
- The company had a working capital deficit of $885,215 as of December 31, 2024.
- The company's continuation as a going concern is dependent on its ability to generate sufficient cash flows or obtain additional financing.
- Smartex Investment Ltd., the majority shareholder, advanced $49,057 to the company for operating expenses during the nine months ended December 31, 2024.
- The company is conducting due diligence for a potential acquisition of a Malaysia-based company, with completion expected in the first half of calendar year 2025.
Sentiment
Score: 2
Explanation: The sentiment is negative due to the company's ongoing losses, significant deficits, going concern uncertainty, and lack of effective internal controls. The potential acquisition offers a glimmer of hope, but its success is far from guaranteed.
Positives
- The company is actively pursuing a potential acquisition to establish business operations.
- The preliminary due diligence for the target acquisition company has been successfully completed.
- Smartex Investment Ltd., the majority shareholder, continues to provide financial support to the company.
Negatives
- The company has not generated any revenue since its inception.
- The company has a significant accumulated deficit of $1,196,015.
- The company has a working capital deficit of $885,215.
- The company's auditors have raised concerns about its ability to continue as a going concern.
- The company's disclosure controls and procedures were not effective as of the end of the period covered by the report.
Risks
- The company's ability to continue as a going concern is uncertain and dependent on obtaining additional financing or generating sufficient cash flows.
- There is no guarantee that the company will be able to access the funding it requires to continue its operations.
- The company's lack of effective disclosure controls and procedures could lead to inaccurate financial reporting.
- The potential acquisition may not be completed or may not be successful if completed.
Future Outlook
The company plans to consider industry guidelines, adopt a business plan, and commence operations through funding and/or acquisition. The due diligence process for the target acquisition is expected to be completed by the first half of calendar year 2025.
Management Comments
- Management believes in the viability of the company's strategy to generate sufficient revenues in the future and in its ability to raise additional funds.
- Management is committed to transparency and will continue to keep stakeholders informed of any significant developments regarding the potential acquisition.
Industry Context
Given the company's lack of operations and reliance on related-party funding, it is difficult to assess its position relative to industry peers. The potential acquisition could represent a significant shift in the company's business model.
Comparison to Industry Standards
- Without any revenue or active operations, it's impossible to compare Xenous Holdings to industry standards.
- Most companies in similar situations would be focusing on securing funding and developing a viable business plan before pursuing acquisitions.
- The company's reliance on related-party funding is not uncommon for early-stage ventures, but it also raises questions about long-term sustainability.
Related Party Transactions
- Smartex Investment Ltd., the majority shareholder, advanced $49,057 and $40,168 to the Company for operating expenses during the nine months ended December 31, 2024 and 2023, respectively.
- As of December 31, 2024 and March 31, 2024, total amount due to Smartex Investment Ltd. was $865,138 and $816,081 respectively.
- The loan is non-interest bearing and due on demand.
Stakeholder Impact
- Shareholders face significant risk due to the company's financial instability and going concern uncertainty.
- The company's employees (if any) may be impacted by potential restructuring or changes in operations.
- Creditors face the risk of non-payment due to the company's financial difficulties.
Next Steps
- Complete due diligence for the potential acquisition of the Malaysia-based company.
- Secure funding to support operations and the potential acquisition.
- Develop and implement a business plan for the acquired company or other ventures.
- Improve disclosure controls and procedures to ensure accurate financial reporting.
Key Dates
| Date | Description |
|---|---|
| May 20, 1980 | Xenous Holdings, Inc. was incorporated as Dayne Weiss and Associates, Inc. |
| December 19, 2014 | The Company completed a change of domicile merger with Concept Holding Corp. |
| July 21, 2017 | The Board of Directors of the Company elected to file Articles of Merger with the Nevada SOS whereby it would enter into a statutory merger with its wholly-owned subsidiary, M101 Corp. |
| August 14, 2017 | The merger took effect and the Company changed its name to M101 Corp. |
| November 2, 2019 | A majority of shareholders approved a resolution to change the name of the Company to Xenous Holdings, Inc. |
| November 19, 2019 | The Company received notice that the Secretary of State of Nevada accepted the Companys Certificate of Amendment to its Articles of Incorporation to change the name of the Company to Xenous Holdings, Inc. |
| March 31, 2024 | Date of audited balance sheet. |
| June 27, 2024 | Date the Company's Form 10-K for the fiscal year ended March 31, 2024 was filed with the Securities and Exchange Commission. |
| December 31, 2024 | End of the quarterly period covered by this report. |
| February 4, 2025 | The number of shares of the issuers common stock outstanding was 760,250,000 shares. |
| February 14, 2025 | Date of report filing. |
Keywords
financial statements, going concern, net loss, working capital deficit, related party transactions, acquisition, Xenous Holdings, 10-Q
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.